SSWM
PCRX icon

Sheets Smith Wealth Management’s Pacira BioSciences PCRX Stock Holding History

Sheets Smith Wealth Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,591
Closed -$673K – 251
2014
Q4 		$673K Buy
+7,591
New +$718K 0.18% 157

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.83B AUM 63.68% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sheets Smith Wealth Management's PCRX Position: Q1 2015 in Review

Sheets Smith Wealth Management sold out of Pacira BioSciences (PCRX) in Q1 2015, closing a stake of 7,591 shares — an estimated $673K sold.

Sheets Smith Wealth Management first reported a position in PCRX in Q4 2014 and held it in 1 quarter. The position peaked at $673K in Q4 2014. 205 funds tracked by Wall St. Rank hold PCRX as of Q1 2015.

  • Sheets Smith Wealth Management reported no remaining Pacira BioSciences position as of Q1 2015 after selling out during the quarter.
  • Sheets Smith Wealth Management sold 7,591 Pacira BioSciences shares in Q1 2015, an estimated $673K.
  • Sheets Smith Wealth Management first reported a position in Pacira BioSciences in Q4 2014 and held it in 1 quarter.
  • Sheets Smith Wealth Management's Pacira BioSciences position peaked at $673K in Q4 2014.
  • 205 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2015.

Based on Sheets Smith Wealth Management's 13F filing for Q1 2015, filed 5 May 2015.